Pressure is the enemy of a diabetic foot ulcer. When peripheral neuropathy strips away protective sensation, a person can keep walking on an open plantar wound without pain, driving mechanical stress into the tissue with every step. This repetitive loading is one of the principal reasons neuropathic ulcers fail to heal. Removing that pressure — a practice clinicians call offloading — is therefore not an optional adjunct but a foundational element of wound care. International guidelines describe offloading as arguably the single most important intervention for healing a neuropathic plantar foot ulcer in a person with diabetes.
Why offloading matters
Diabetic foot ulcers carry serious consequences. They are associated with a roughly twelvefold increase in the risk of lower-extremity amputation and with elevated mortality, which is why timely, effective treatment is critical. The biomechanical logic of offloading is straightforward: a plantar ulcer sits beneath a region of concentrated peak pressure, and unless that pressure is redistributed, the wound bed is repeatedly disrupted before it can close. Effective offloading devices work by spreading load across a larger surface area and away from the ulcer site, allowing the tissue the mechanical rest it needs to granulate and re-epithelialize.
The evidence for this approach is mature. Randomized controlled trials conducted over several decades have shown that neuropathic plantar ulcers heal in an average of around six weeks when treated with a total contact cast, a level of evidence that few other wound interventions can match.
The hierarchy of offloading devices
Not all offloading is equal, and the major guidelines set out a clear order of preference. The 2019 update of the International Working Group on the Diabetic Foot (IWGDF) guideline, carried forward into the 2023 IWGDF framework, recommends a nonremovable knee-high device — a total contact cast (TCC) or a non-removable knee-high walker — as the first-choice treatment for a neuropathic plantar forefoot or midfoot ulcer.
The central reason a nonremovable device outperforms a removable one is adherence. A removable boot only offloads the wound while it is actually being worn, and patients frequently take such devices off. A cast or rendered-irremovable walker cannot be removed at will, so it offloads the foot continuously. When contraindications or patient intolerance make a nonremovable device unsuitable, the guideline positions a removable knee-high device as the second choice and a removable ankle-high device as the third, with appropriately fitting footwear combined with felted foam as a fourth-line option. When nonsurgical offloading fails, surgical offloading procedures may be considered for metatarsal-head and digital ulcers.
What the pressure data show
Biomechanical studies help explain the hierarchy. Comparative work measuring peak plantar pressure across devices found that the total contact cast, removable cast walkers, and braced removable casts all produced significant pressure reductions across most regions of the foot relative to a control condition. Such studies consistently conclude that the TCC remains the gold standard and first-line option for offloading diabetic foot ulcers, while also clarifying which alternative devices come closest to matching its performance.
The gap between evidence and practice
Despite this strong and long-standing evidence, gold-standard devices remain underused in everyday care. A survey of prosthetic and orthotic clinics in Sweden found that most practitioners treated neuropathic plantar forefoot ulcers with modified off-the-shelf footwear and insoles — precisely the approach guidelines recommend against — while total contact casts were provided by only about a fifth of clinicians and nonremovable knee-high walkers by none. The authors noted that the prevailing practice pattern was almost exactly the opposite of what the evidence supports, and they linked this partly to limited awareness of which devices are considered the gold standard.
This evidence-to-practice gap matters because the choice of device has direct consequences for healing time, infection risk, and ultimately limb preservation. Barriers to casting are real: total contact casts require trained application, can affect a patient’s mobility and ability to drive, and demand careful technique to avoid iatrogenic skin damage. Researchers have explored alternatives that preserve the nonremovable advantage with fewer drawbacks. One retrospective comparison of a nonremovable total contact softcast against a conventional total contact cast reported broadly similar healing ratios, suggesting that lighter, better-tolerated nonremovable constructions may be a reasonable option, though the authors called for randomized confirmation.
Key takeaways
Offloading is the mechanical cornerstone of healing the neuropathic diabetic foot ulcer. The best available evidence favors nonremovable knee-high devices, particularly the total contact cast, as first-line treatment, with a structured cascade of removable and footwear-based options when casting is not feasible. Surgical offloading has a defined role when conservative measures fail. Perhaps the most actionable lesson from recent literature is that effective devices already exist but are underutilized; closing the gap between guideline recommendations and routine practice represents a clear opportunity to shorten healing times and reduce the burden of infection and amputation associated with diabetic foot ulcers.
References
Bus SA, Armstrong DG, Gooday C, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes/Metabolism Research and Reviews. 2020;36(Suppl 1):e3274.
Bus SA, Monteiro-Soares M, Game F, et al. Standards for the development and methodology of the 2023 IWGDF guidelines. Diabetes/Metabolism Research and Reviews. 2023;40(3):e3656.
Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of Vascular Surgery. 2016;63(2 Suppl):3S-21S.
Carter SL, Law JHM, Seyler N, et al. Removable and Nonremovable Off-Loading Devices. Journal of the American Podiatric Medical Association. 2025;115(3).
Gigante I, Sigurjónsdóttir ED, Jarl G, Hellstrand Tang U. Offloading of diabetes-related neuropathic foot ulcers at Swedish prosthetic and orthotic clinics. Diabetes/Metabolism Research and Reviews. 2023;39(4):e3611.
Vierhout BP, Visser R, Hutting KH, et al. Comparing a non-removable total contact cast with a non-removable softcast in diabetic foot ulcers: A retrospective study of a prospective database. Diabetes Research and Clinical Practice. 2022;191:110036.
Comments
